Gonorrhea Female
3
1
1
0
Key Insights
Highlights
Treatment Research
6 treatments under study, led by Cepheid Xpert Ctng Rapid Turnaround Test
Research Leaders
8 sponsors active, led by National Institute Of Allergy And Infectious Diseases Niaid
Related Conditions
Often studied with 9 related conditions
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 80/100
33.3%
1 terminated out of 3 trials
0.0%
-86.6% vs benchmark
33%
1 trials in Phase 3/4
0%
1 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (3)
The Integrated Female Sexually Transmitted Infection Testing for HIV Epidemic Control Through PrEP (IN-STEP) Study
A Randomized Controlled Trial of Doxycycline Post Exposure Prophylaxis to Prevent Incident Bacterial STIs Among Women in the United States
Use of a Rapid Test for Gonorrhea & Chlamydia for Women Presenting With Possible Sexually Transmitted Infections
Research Network
Common Treatments
- Cepheid Xpert Ctng Rapid Turnaround Test1
- Selfreported Risk Screening For Prep And Syndromic Management For Stis1
- Selfreported Risk Screening For Prep And Diagnostic Sti Testing1
- Polymerase Chain Reaction Pcr1
- Doxycycline1
Active Sponsors
- National Institute Of Allergy And Infectious Diseases Niaid2
- Abbott1
- University Of Alabama At Birmingham1
- University Of Maryland Baltimore1
- Bill And Melinda Gates Foundation1
Related Conditions
- Chlamydia Females3
- Syphilis Female2
- Sexually Transmitted Infection1
- Prophylaxis1
- Prevention1